Fair Isaac Corporation (LON:0TIQ)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	25,027	35,553	17,692	9,337	8,366	9,539
Market Cap Growth	11.58%	100.96%	89.48%	11.60%	-12.29%	33.77%
Enterprise Value	26,998	37,042	19,174	10,993	9,015	10,240
Last Close Price	1023.57	1441.88	714.95	375.16	296.51	328.37
PE Ratio	54.20	92.92	50.28	27.85	28.81	52.18
PS Ratio	17.78	27.75	14.26	7.55	8.58	9.53
PB Ratio	-24.54	-49.50	-31.38	-12.97	-101.82	37.26
P/FCF Ratio	44.24	76.36	47.08	20.67	27.14	35.97
P/OCF Ratio	43.87	75.28	46.04	20.42	26.65	33.80
EV/Sales Ratio	18.54	28.91	15.46	8.89	9.24	10.23
EV/EBITDA Ratio	38.97	66.42	35.69	21.76	27.80	35.83
EV/EBIT Ratio	40.42	67.67	36.51	22.58	29.45	38.83
EV/FCF Ratio	47.72	79.55	51.03	24.33	29.24	38.62
Debt / Equity Ratio	-2.00	-2.34	-2.76	-2.38	-12.03	2.83
Debt / EBITDA Ratio	3.05	2.94	2.82	3.28	2.91	2.35
Debt / FCF Ratio	3.61	3.61	4.15	3.80	3.21	2.73
Asset Turnover	1.08	1.04	1.00	0.92	0.83	0.85
Quick Ratio	0.84	1.52	1.43	1.38	0.91	1.19
Current Ratio	0.92	1.62	1.51	1.46	0.99	1.29
Return on Equity (ROE)	-	-	-	-	356.21%	76.16%
Return on Assets (ROA)	30.98%	27.85%	26.55%	22.53%	16.28%	14.02%
Return on Capital (ROIC)	40.59%	36.62%	34.47%	29.05%	20.74%	17.86%
Return on Capital Employed (ROCE)	81.10%	54.80%	53.10%	48.80%	41.00%	28.60%
Earnings Yield	1.85%	1.08%	1.99%	3.59%	3.47%	1.92%
FCF Yield	2.26%	1.31%	2.12%	4.84%	3.69%	2.78%
Buyback Yield / Dilution	1.63%	1.14%	3.72%	9.96%	2.25%	1.20%
Total Shareholder Return	-	1.14%	3.72%	9.96%	2.25%	1.20%

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.